Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
05/2002
05/16/2002WO2002039121A2 Methods for detecting the efficacy of anticancer treatments
05/16/2002WO2002039120A1 A method for identifying the proteome of cells using an antibody library microarray
05/16/2002WO2002039119A2 Method for assaying protein nitrosylation
05/16/2002WO2002039118A1 Screening methods for bone morphogenetic mimetics
05/16/2002WO2002039117A1 Methods for the treatment of cellular proliferative disorders
05/16/2002WO2002039115A2 Detection of allergen-associated materials
05/16/2002WO2002039114A2 Improved assay and reagents or immunological determination of analyte concentration
05/16/2002WO2002039113A2 Schiff base reductant co-dispense process
05/16/2002WO2002039111A1 Supports for hybridization and method of immobilizing hybrid
05/16/2002WO2002039110A2 A method for the quantification of carbohydrates
05/16/2002WO2002039109A2 Method for the detection of human hematopoietic short term repopulating cells
05/16/2002WO2002039108A1 A method for turbidity and conductivity measurements online in fibre suspensions
05/16/2002WO2002039107A1 Water monitoring device
05/16/2002WO2002039103A1 Thin film metal hydride hydrogen sensor
05/16/2002WO2002039098A1 Test kit for simultaneously detecting several types of residues
05/16/2002WO2002039093A1 Method and device for determining the swelling behavior of polymer gels under pressure
05/16/2002WO2002039086A2 Glucose sensor system
05/16/2002WO2002039083A2 Fluorescence and fret based assays for biomolecules on beads
05/16/2002WO2002038811A2 Assay for the detection and quantitation of hemimethylation
05/16/2002WO2002038810A2 Compositions and methods relating to prostate specific genes and proteins
05/16/2002WO2002038807A1 Method for screening agents capable of treating obesity
05/16/2002WO2002038805A2 Eukaryotic cell division genes and their use in diagnosis and treatment of proliferative diseases
05/16/2002WO2002038800A1 Test piece for assaying high density lipoprotein (hdl) cholesterol
05/16/2002WO2002038797A2 Modulators of bruton's tyrosine kinase, their identification and use
05/16/2002WO2002038796A2 Methods for determining protease cleavage site motifs
05/16/2002WO2002038795A2 Braf35 protein and brca2/braf35 complex and methods of use
05/16/2002WO2002038794A2 Cardiovascular disease diagnostic and therapeutic targets
05/16/2002WO2002038793A2 Hepatitis c virus constructs characterized by high efficiency replication
05/16/2002WO2002038778A1 Differentiation-inducing substances
05/16/2002WO2002038759A2 Method for inducing apoptiosis
05/16/2002WO2002038758A1 Lysate clearance and nucleic acid isolation using silanized silica matrices
05/16/2002WO2002038744A2 Proteases
05/16/2002WO2002038734A2 Methods for determining the biological effects of compounds on gene expression
05/16/2002WO2002038732A2 Human testis specific serine/threonine kinase
05/16/2002WO2002038731A2 Method for measuring nucleotides
05/16/2002WO2002038730A2 Novel human potassium channel beta subunit
05/16/2002WO2002038724A2 A method for the detection of viable microorganisms
05/16/2002WO2002038678A1 Efficient cyclic-bridged cyanine dyes
05/16/2002WO2002038608A2 Methods of screening for ltrpc2 modulators
05/16/2002WO2002038607A2 A 'bach' g protein coupled receptor polypeptide and polynucleotide encoding this receptor
05/16/2002WO2002038600A2 C. elegans genes involved in viability and/or reproduction and uses thereof
05/16/2002WO2002038596A1 Method of identifying antibacterial compounds
05/16/2002WO2002038594A1 Novel therapeutic compositions for treating infection by lawsonia spp
05/16/2002WO2002038593A1 Haemophilus antigen
05/16/2002WO2002038580A1 Streptavidin-binding peptides and uses thereof
05/16/2002WO2002038579A1 Compositions and methods for identifying agents which regulate chromosomal stability, gene activation and aging
05/16/2002WO2002038298A1 Method and system to remotely monitor groundwater treatment
05/16/2002WO2002038189A1 Absolute lymphocyte recovery and cancer survival
05/16/2002WO2002038173A1 Vaccine based on a cellular penetration factor from an apicomplexan parasite
05/16/2002WO2002038143A2 Enhanced efficacy and safety of genotoxic therapy by p38 mapk modulation
05/16/2002WO2002038108A2 Methods of treating disorders related to apoe
05/16/2002WO2002038035A2 Methods for inhibiting pain
05/16/2002WO2002038032A2 Methods and devices for collecting and processing mammary fluid
05/16/2002WO2002020823A3 Methods and compositions for visualizing and interfering with chromosomal tethering of extrachromosomal molecules
05/16/2002WO2002020141A8 Device and method for separating undissolved constituents out of biological fluids
05/16/2002WO2002020054A3 Methods of treatment and diagnosis of hcv infection in cns based on magnetic resonance spectroscopy
05/16/2002WO2002020003A3 Use of carp inhibitors for the treatment of heart diseases
05/16/2002WO2002017902A8 Gene conferring resistance to the antibacterial 4,5-dihydroxy-2-cyclopenten-1-one (dhcp), the protein encoded by same, and applications thereof
05/16/2002WO2002012888A3 Capsules encapsulating solid particles of signal-generating organic substances
05/16/2002WO2002009012A3 Accessibility correction factors for electronic models of cytochrome p450 metabolism
05/16/2002WO2002008722A3 Direct assessment of relative concentrations of variants of an epitope on a dimeric molecule
05/16/2002WO2002002806A3 Method and nucleic acids for analysing the methylation of genes implicated in pharmacogenomics
05/16/2002WO2001096593A3 Novel motor proteins and methods for their use
05/16/2002WO2001094629A8 Cancer gene determination and therapeutic screening using signature gene sets
05/16/2002WO2001092496A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
05/16/2002WO2001088533A3 Lipid uptake assays
05/16/2002WO2001088098A3 Fertilization of aged oocytes
05/16/2002WO2001087335A3 Method for selectively inhibiting ghrelin action
05/16/2002WO2001086288A3 Early diagnosis of bladder tumor in urine samples
05/16/2002WO2001085913A3 High purity x-chromosome bearing and y-chromosome bearing populations of spermatozoa
05/16/2002WO2001081622A8 Diagnosis of diseases associated with dna repair
05/16/2002WO2001079843A3 Screening method for compounds
05/16/2002WO2001079492A3 Lipid binding protein 3
05/16/2002WO2001077670A3 Homocysteine assay
05/16/2002WO2001073444A3 Receptor/peptide crystal structure for identification of inhibitors
05/16/2002WO2001071357A3 Diagnosis and treatment of breast cancer
05/16/2002WO2001071304A3 Capstans for proof testing of optical fibres
05/16/2002WO2001070953A3 Identification of modulators of the inteferon gamma signaling pathway and their use in restenosis treatment
05/16/2002WO2001069261A3 Proteins, genes and their use for diagnosis and treatment of vascular dementia
05/16/2002WO2001067097A3 Method of identifying modulators of presenilin
05/16/2002WO2001065461A3 Process for estimating random error in chemical and biological assays
05/16/2002WO2001065253A3 Non-destructive method for controlling wooden poles in particular electrical or telephone network poles
05/16/2002WO2001063298A3 Diagnosis of cvd measuring folate and holo-tcii
05/16/2002WO2001061305B1 Immunoassays detecting or making use of at least two rubber latexallergens
05/16/2002WO2001057237A3 Methods employing increased dye-fluorescence upon nitroreduction
05/16/2002WO2001055952A8 Method and system for collecting and transmitting chemical information
05/16/2002WO2001047959A3 Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof
05/16/2002WO2001035820A9 Tissue interface device
05/16/2002WO2001034765A9 Methods and apparatus for the electronic, homogeneous assembly and fabrication of devices
05/16/2002WO2001034636A9 Gridlock nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
05/16/2002WO2001032928A9 Methods of determining individual hypersensitivity to an agent
05/16/2002WO2001032685A8 Gene expression directed by a super-psa promoter
05/16/2002WO2001031346A9 Identification of novel pro- and anti-angiogenic agents
05/16/2002WO2001029255A3 Diagnostic test for cephalic pain
05/16/2002WO2001025480A3 Dna sequencing method
05/16/2002WO2001025408A9 Isolated dishevelled associated kinases, polynucleotides encoding the kinases, and methods of use thereof
05/16/2002US20020059653 Modulating protein complex formation in cells; obtain sample tissue, incubate with acetylcholine esterase, expose to modulator, monitor sample for complex formation
05/16/2002US20020059652 Detecting modulators of liver cell propagation, cell differentiation and lymphocyte activity; obtain modulator, incubate with indicator, mix with culture monitor culture for adjustment in activity
05/16/2002US20020059033 Emission monitoring system and method
05/16/2002US20020058902 Tissue ablation by shear force for sampling biological fluids and delivering active agents